Malaria Indicator Selection Framework
A guide for selecting appropriate Global Fund performance monitoring indicators
Start
How to Use Genially
Navigation Features
Logic Model Table of Contents
Indicator Details
Use the four buttons on the top left of the screen to navigate through the Indcator Selection Frameworks.
Use the table of contents (page 6) to navigate between logic models. The logic models are organized by Global Fund module. Click the home button in the top left corner to return to the table of contents.
Within each logic model, click an indicator box to open a details window. This window includes the indicator definition, disaggregations, data sources, and other key information.
Go to Logic Model Table of Contents
CODE
Go back to previous page
Click on me!
Go to next page
Use the button on the top right to reveal all interactive elements that can be clicked
Open Logic Model key
INPUT
Page 2
Indicator Selection Frameworks Overview
PURPOSE: The Indicator Selection Frameworks are designed to assist in selecting appropriate Global Fund indicators for each intervention. They provide systematic guidance to ensure a comprehensive selection process that meets both mandatory requirements and best practice recommendations. The tool ensures inclusion of all required indicators for each intervention and facilitates the selection of additional indicators to support effective program monitoring. These indicators help measure intervention coverage, outcomes, and the overall impact of malaria interventions. Upon completing this process, users will have a comprehensive list of indicators suitable for inclusion in the Performance Framework.
AUDIENCE: Public Health Monitoring & Evaluation Specialists (PHMES) and Principal Recipients (PRs)
LOGIC MODELS: There are nine logic models, each representing a distinct Global Fund intervention, such as Seasonal Malaria Chemoprevention (SMC), Indoor Residual Spraying (IRS), etc. Each model outlines the inputs, activities/outputs, outcomes, and impacts associated with the intervention. Global Fund malaria indicators have been systematically mapped to their corresponding positions within each logic model.
INPUT
ACTIVITIES/OUTPUTS
OUTCOMES
INPUTS
IMPACTS
IMPACT INDICATORS: The impact indicators are essential and span across all interventions. Since interventions work collectively to achieve the desired impact, these indicators are presented separately. It is recommended that grantees select indicators I-3.1 and I-10, plus at least two additional impact indicators to enable triangulation.Click here to go to the impact indicators.
Page 3
Indicator Selection Frameworks Overview
INDICATOR SUMMARY TABLES: In addition to the logic models, each page includes a summary table listing the relevant Group 1 mandatory indicators, intervention-specific mandatory indicators, recommended non-mandatory indicators, and relevant Resilient and Sustainable Systems for Health (RSSH) grant indicators. For some interventions, different indicators are recommended depending on whether recent Demographic and Health Survey (DHS) or Multiple Indicator Cluster Survey (MICS) results are available.
RSSH INIDICATORS: Where relevant, RSSH indicators have been included to highlight their relevance to malaria interventions. These indicators provide important contextual information that supports the interpretation of malaria-specific data. Grants that include RSSH funding should consider selecting these indicators. However, they are not intended to replace core malaria indicators.
DISAGGREGATIONS: If a selected indicator includes disaggregations, all disaggregated data must be reported. Some disaggregations may be more relevant to specific interventions. If the indicator is collected through a small area survey such as Lot Quality Assurance Sampling (LQAS), disaggregated data may not be feasible to collect due to the limited sample size.
INPUT
Page 4
Indicator Selection Frameworks Overview
RELATED DOCUMENTATION:
The Indicator Selection Framework should be used in conjunction with the following complementary documents:
* Click on document name to open
Global Fund Malaria Indicator Guidance Sheet
Global Fund Modular Framework Handbook
INPUT
Page 4
Indicator Selection Workbook
Download the linked Indicator Selection Workbook and use it alongside the Indicator Selection Frameworks. The workbook can be used to track the indicators selected for inclusion in the grant and the Performance Framework.
Click here to open the Indicator Selection Workbook.
INPUT
Page 4
Key - Example Logic Model
CODE
Elimination Indicator
Non-mandatory indicator recommended for elimination contexts only.
CODE
RSSH Indicator
Grants with RSSH funding should consider reporting this indicator
Indicates a note related to this activity. See bottom right corner of the logic model for details.
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
CM-1A
O-13
CM-10
RSSH O-3
CM-1B
CM-1C
CODE
Non-Mandatory Indicator
Non-mandatory indicator applicable to all settings.
CODE
Group 1 (Mandatory)
This is a mandatory indicator for all grants receiving funding for the intervention and is used in calculating the grant’s Performance Rating.
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
CM-7
CODE
Intervention-Specific Mandatory Indicator
Grants receiving funding for interventions (e.g., G6PD testing, private sector testing, etc.) are required to report on these indicators.
Page 5
Notes related to the asterisk will appear here.
Indicator Selection Frameworks
SEASONAL MALARIA CHEMOPREVENTION
PERENNIAL MALARIA CHEMOPREVENTION
SPI MODULE
KEY
Note: color corresponds to intervention
INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY
Group 1 (Mandatory)
CODE
Intervention-specific Mandatory Indicator
INSECTICIDE TREATED NET MASS CAMPAIGNS
CODE
VECTOR CONTROL MODULE
Reduced malaria incidence and prevalence
Reduced malaria mortality
INSECTICIDE TREATED NET CONTINOUS CAMPAIGNS
Elimination Indicator
CODE
INDOOR RESIDUAL SPRAYING
Non-mandatory Indicator
CODE
CODE
RSSH Indicator
CASE DETECTION: ELIMINATION SETTINGS
CASE MANAGEMENT MODULE
CASE DETECTION: HIGH/MIXED BURDEN
CASE TREATMENT
* Click on the intervention to go to the corresponding logic model *
Page 6
SEASONAL MALARIA CHEMOPREVENTION (SMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement targeted campaigns to administer SMC to children in target age groups during peak transmission seasons
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of SMC as recommended
Decrease in malaria mortality in children
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure SMC medications and identify target districts
Distribute adequate supply of SMC medications to implementing districts before peak transmission season
RSSH O-3
SPI-2.1
Districts monitor and achieve target SMC coverage among children in the target age group
SPI-5
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 7
SEASONAL MALARIA CHEMOPREVENTION (SMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement targeted campaigns to administer SMC to children in target age groups during peak transmission seasons
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of SMC as recommended
Decrease in malaria mortality in children
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure SMC medications and identify target districts
Distribute adequate supply of SMC medications to implementing districts before peak transmission season
RSSH O-3
SPI-2.1
Districts monitor and achieve target SMC coverage among children in the target age group
SPI-5
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 7
PERENNIAL MALARIA CHEMOPREVENTION (PMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure PMC medications and identify target districts
Administer PMC to children in target age group in perennial transmission areas through EPI or other distribution channels
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of PMC as recommended
Decrease in malaria mortality in children
Distribute adequate supply of PMC medications to implementing districts for year-round administration
SPI-3.1
RSSH O-3
Establish integrated malaria services within Expanded Program on Immunization
(EPI)
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 8
INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY (IPTp)
OUTCOMES
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
* Click on indicator for additional information *
Distribute adequate supply of IPTp medications to facilities and communities in implementing districts
Administer recommended doses of IPTp to pregnant women and girls through ANC and community-based services
Pregnant women and girls receive IPTp through ANC and community-based services
Pregnant women and girls receive first dose of IPTp
Decrease in malaria related pregnancy complications and low-weight and premature births
Decrease in malaria-associated mortality among pregnant women and girls, and among neonates
Conduct planning using local epidemiological data, along with programmatic gap tables, to procure IPTp medications for target districts
O-17
RSSH O-3
Pregnant women and girls receive 3+ doses of IPTp
Establish integrated malaria services within antenatal care (ANC)
SPI-1
Districts monitor and achieve target IPTp coverage among pregnant women and girls
SPI-4
Page 9
ITN MASS CAMPAIGNS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
IMPACTS
* Click on indicator for additional information *
Conduct social and behavior change (SBC) activities related to ITN use
Distribute adequate supply of ITNs to implementing districts
Distribute ITNs to at-risk populations through mass campaigns
Increase in at-risk population sleeping under ITNs
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Decrease in malaria mortality across all age groups
Population at risk receives ITN and has access to an ITN within their household
Conduct planning using local epidemiological and entomological data, along with programmatic gap tables, to procure effective ITNs for implementing districts
O-3
O-1a
O-10
VC-1
O-2
Participating districts
implement and track ITN distribution activities to achieve target population coverage
O-11
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 10
ITN CONTINUOUS DISTRIBUTION
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
IMPACTS
* Click on indicator for additional information *
Conduct SBC activities related to ITN use
Increase in at-risk population sleeping under ITNs
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Decrease in malaria mortality across all age groups
Distribute an adequate supply of ITNs for each distribution channel including, as relevant: ANC, EPI, schools, and community
Population at risk receives ITN and has access to an ITN within their household
Conduct planning using local epidemiological and entomological data, along with programmatic gap tables, to procure effective ITNs for implementing districts
Distribute ITNs to at-risk populations through ANC, EPI, school, and community delivery channels
VC-3
O-3
O-1a
O-10
O-2
Participating districts
implement and track ITN distribution activities to achieve target population coverage
O-11
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 11
INDOOR RESIDUAL SPRAYING (IRS)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement IRS campaign
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Households and structures are sprayed using appropriate insecticide to achieve target population coverage in all targeted areas
Decrease in malaria mortality across all age groups
Conduct planning using local epidemiological and entomological data, the number of structures requiring spraying, and programmatic gap tables to procure effective IRS insecticides for implementing districts
Distribute adequate supply of residual insecticides to implementing districts
VC-6.1
Participating districts implement and track IRS activities to achieve target population coverage in each district
VC-7
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 12
CASE MANAGEMENT: CASE DETECTION (ELIMINATION SETTINGS)
ACTIVITIES / OUTPUTS
INPUTS
OUTCOMES
ACTIVE CASE DETECTION
Detect and report symptomatic and asymptomatic malaria cases among screened population
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Screen at-risk populations for malaria using RDT or microscopy
Investigate and classify confirmed malaria cases and foci
Proceed to Treatment Pathway
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
O-13
CM-6
CM-10
CM-5
RSSH O-3
O-9
Conduct SBC activities related to malaria case management
PASSIVE CASE DETECTION
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
CM-1A
CM-9
O-13
CM-10
RSSH O-3
CM-1B
CM-1C
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
Following foci investigation, targeted mass drug administration (MDA) may be conducted to support elimination efforts or reduce transmission
Page 13
CM-7
CASE MANAGEMENT: CASE DETECTION (HIGH-BURDEN SETTINGS)
ACTIVITIES / OUTPUTS
INPUTS
OUTCOMES
* Click on indicator for additional information *
Conduct SBC activities related to malaria case management
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
Proceed to Treatment Pathway
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
CM-1A
RSSH O-3
O-13
CM-1B
CM-1C
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
CM-7
Page 14
CASE MANAGEMENT: TREATMENT (ALL SETTINGS)
OUTCOMES
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
* Click on indicator for additional information *
Health care providers test for patients with
P. vivax to assess G6PD deficiencies
Patients with P. vivax receive G6PD deficiency testing before being prescribed treatment
Decrease in severe malaria requiring admission
Conduct SBC activities related to malaria case management
CM-11
P.vivax
Distribute adequate supply of antimalarials and G6PD tests to implementing districts
Patients with confirmed malaria receive treatment with appropriate first-line antimalarials
Health care providers prescribe appropriate first-line treatment to patients with confirmed malaria
Parasite is cleared
Decrease in transmission due to early identification and treatment in cases
Decrease in malaria mortality in all age groups
Conduct planning using local epidemiological data, therapeutic efficacy studies, and programmatic gap tables to procure effective antimalarials and G6PD tests for implementing districts
CM-2A
RSSH O-3
CM-2B
Adequate number of healthcare providers
Elimination settings: Districts achieve subnational elimination of cases
CM-2C
Participating districts implement treatment protocols to achieve target treatment rates among confirmed malaria cases
RSSH/PP O-3
CM-8
Page 15
CROSS-INTERVENTION IMPACT INDICATORS
Impact indicators are cross-cutting across interventions and are used to track progress toward primary objectives, such as reductions in case incidence and mortality rates. It is recommended that grants select I-3.1, I-10, and at least 2 additional impact indicators to support triangulation.
Page 16
SPI-1: Proportion of pregnant women and girls attending antenatal services who received three or more doses of intermittent preventive treatment for malaria.
DISAGGREGATIONS: Age (<15, 15+)DATA SOURCE: HMIS/routine surveillance systemINFO: SPI-1 is a mandatory Group 1 indicator required for all grants implementing IPTp. SPI-1 measures completion rates of three or more recommended doses of IPTp.
Click here to go to the example logic model with key
Click here to go to the example logic model with key
Click here to go to the example logic model with key
CM-2B: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, in the community.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator & Denominator: Malaria treatment register/ Community worker records
INFO: CM-2B must be collected by grants where community treatment is funded. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.
O-2: Proportion of population with access to an ITN within their household.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-2 measures household-level ITN availability and is key for evaluating whether distribution translates into accessible protection for all household members. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups.
SPI-3.1: Proportion of children in the target age group who received the full number of doses of perennial malaria chemoprevention (PMC) according to national policy.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: Grants implementing PMC must collect SPI-3.1. This indicator is a critical metric for measuring program coverage and completion rates of the required PMC course.
O-2: Proportion of population with access to an ITN within their household.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-2 measures household-level ITN availability and is key for evaluating whether distribution translates into accessible protection for all household members. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups.
Click here to go to the example logic model with key
Click here to go to the example logic model with key
CM-10: Proportion of cases reported to relevant reporting system within 24 hours of diagnosis (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric for surveillance capacity monitoring particularly in elimination settings, where the target should be to achieve full coverage for this indictor. This indicator helps to assess promptness of reporting to the relevant national system.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted
INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of SMC supplies and provides essential context for interpreting other SMC indicators. When SMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
CM-11: Proportion of P. vivax cases tested for G6PD deficiency.
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: CM-11 must be measured in all grants where G6PD testing is funded. This indicator is relevant for settings with P. vivax or mixed infections where treatment with primaquine or tafenoquine would be required for clearance of the liver stage of the parasite. This indicator assesses trends in testing coverage for G6PD deficiency in patients receiving primaquine or tafenoquine for radical cure of P. vivax.
CM-1B: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) in the community.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1B must be collected for grants where funding is allocated towards community testing programs.
O-3: Proportion of the population with access to an ITN in their household that slept under an ITN the previous night.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-3 measures actual ITN utilization among those with access to an ITN to assess behavioral uptake and real protection achieved. This indicator is suitable especially in burden reduction settings where national population-based surveys and/ or small area surveys are planned. It should be included and the source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. The indicator could be calculated by dividing O-1a (numerator) by O-2 (denominator).
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of PMC supplies and provides essential context for interpreting other PMC indicators. When PMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
O-17: Number of women receiving one dose of IPTp.
DISAGGREGATIONS: N/ADATA SOURCE: HMIS (ANC and community registers)INFO: As countries diversify the avenues for the delivery of IPTp beyond the ANC clinics, this indicator seeks to assess access to at least one dose of IPTp in the health facility or community. O-17 helps programs understand uptake of the first IPTp dose during pregnancy, while SPI-1 measures completion rates of three or more recommended doses. While O-17 is not factored into grant performance evaluations, it provides essential context for interpreting SPI-1 results.
SPI-5: Percentage of targeted districts achieving national targets for the percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: SPI-5 serves as a critical indicator for understanding subnational variation in SMC completion rates in children. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine surveillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.
RSSH/PP O-3: Density of active health workers per 10,000 population.
DISAGGREGATIONS: Occupation group (Physicians, Nurses, Midwives, Laboratory technicians, Pharmacists, CHWs) DATA SOURCE: Human Resources Health Information System (HRHIS) or any other Health WorkfoRce registry or database. INFO: RSSH/PP O3 assesses whether there are sufficient health workers available to provide malaria treatment.
O-3: Proportion of the population with access to an ITN in their household that slept under an ITN the previous night.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-3 measures actual ITN utilization among those with access to an ITN to assess behavioral uptake and real protection achieved. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and the source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. The indicator could be calculated by dividing O-1a (numerator) by O-2 (denominator).
Click here to go to the example logic model with key
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine surveillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine survillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.
CM-1C: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at private sector sites.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1C must be collected for grants where funding is allocated towards private testing programs.
O-10: Proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution
- Denominator: Pre-distribution census/ census projection
INFO: O-10 measures theoretical population coverage to assess distribution adequacy relative to at-risk populations. The indicator is critical for evaluating whether sufficient nets are distributed to achieve protective coverage. This indicator becomes increasing useful as the paucity of data from population-based surveys becomes a real challenge for programmatic monitoring of trends in access to vector control interventions, particularly ITNs.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support passive case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
SPI-5: Percentage of targeted districts achieving national targets for the percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: SPI-5 serves as a critical indicator for understanding subnational variation in SMC completion rates in children. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of IPTp supplies and provides essential context for interpreting other IPTp indicators. When IPTp coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
O-10: Proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution
- Denominator: Pre-distribution census/ census projection
INFO: O-10 measures theoretical population coverage to assess distribution adequacy relative to at-risk populations. The indicator is critical for evaluating whether sufficient nets are distributed to achieve protective coverage. This indicator becomes increasing useful as the paucity of data from population-based surveys becomes a real challenge for programmatic monitoring of trends in access to vector control interventions, particularly ITNs.
CM-1A: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at a public sector health facility.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1A is a Group 1 indicator and must be measured by all grants implementing case management activities.
CM-1C: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at private sector sites.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1C must be collected for grants where funding is allocated towards private testing programs.
O-9: Annual blood examination rate (ABER): Number of people receiving a parasitological test during 1 year out of the total population at risk.
DISAGGREGATIONS: Case detection (active, passive)DATA SOURCE: Health information system/routine surveillance systemINFO: Analysis of ABER enables assessing malaria diagnostic effort through analysis of the number of patients receiving a parasitological test for malaria (blood slide for microscopy or malaria rapid diagnostic test) out of the total population living in malarious areas.
CM-7: Percentage of districts achieving national target for the proportion of patients with suspected malaria who receive a parasitological test.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-7 is recommended to be collected by all grants receiving funding for Case Management. This indicator enables assessing sub-national variations in malaria diagnostic testing coverage among suspected cases of malaria visiting public, community, and private sector health facilities. It informs decisions on prioritization and targeting of subnational units for differentiated support (expansion of testing services, commodities, training, supervision, etc.).
SPI-2.1: Percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- Health management information system (HMIS)/routine surveillance system
INFO: Grants implementing SMC must collect SPI-2.1 (Group 1 indicator). This indicator is a critical metric for measuring program coverage and completion rates of the required SMC course.
Click here to go to the example logic model with key
CM-5: Proportion of confirmed cases classified (elimination settings).
DISAGGREGATIONS: Source of infection (indigenous, introduced, relapsing, recrudescent, induced, imported)DATA SOURCE: HMIS/routine surveillance systemINFO: The indicator enables assessing compliance with the third component (tracking) of the test, treat and track (T3) cascade, in elimination settings. It also helps to assess the promptness of the surveillance system. Countries may have their own rules on reporting, investigation and classification (e.g., 1,3, 7-day rule, etc.).
CM-9: Proportion of detected malaria patients that contacted health services within 48 hours of symptoms (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric of prompt access to care, particularly in elimination settings, where the target should be to achieve full coverage for this indictor.
Click here to go to the example logic model with key
Indicator Additional Details – Example View
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine survillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimateed cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.
CM-2C: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, at private sector sites.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator and denominator: OPD register/Malaria treatment register/ Pharmacy/ records
INFO: CM-2C should be measured in grants where private treatment is funded. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.
CM-1A: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at a public sector health facility.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1A is a Group 1 indicator and must be measured by all grants implementing case management activities.
Click here to go to the example logic model with key
O-11: Percentage of districts achieving national target for the proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution & list of districts eligible for ITN distribution
- Denominator: Pre-distribution census/ census projection; and list of districts eligible for ITN distribution
INFO: O-11 is a highly recommended indicator that enables assessment of sub-national variations in access to ITNs. The analysis for this indicator informs decisions on prioritization and subnational targeting for differentiated support.
VC-7: Percentage of districts achieving national target for the proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS.
DISAGGREGATIONS: N/ADATA SOURCE: Malaria program records for IRSINFO: VC-7 is highly recommended for grants implementing IRS. VC-7 measures geographic equity in IRS delivery by tracking district-level performance against national standards. This indicator is essential for identifying underperforming areas and optimizing resource allocation for vector control.
CM-8: Percentage of districts achieving national targets for the proportion of patients with confirmed malaria who received first-line antimalarial treatment.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-8 is a highly recommended indicator in combination with the CM-2 series. This indicator enables assessment of sub-national variations in first-line treatment coverage among confirmed cases of malaria diagnosed at public, community, and private sector health facilities. It informs decisions on prioritization and targeting of sub-national units for differentiated support - in terms of interventions, approaches, technical support, and supervision.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support case treatment by assessing antimalarial supply availability at health facilities. This indicator is critical for understanding the availability of treatment supplies and provides essential context for interpreting other case management treatment indicators. When treatment coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
VC-3: Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution.
DISAGGREGATIONS: At risk population group (Children 0-5, Pregnant women, School children, people in emergency situation, others)DATA SOURCE:
- HMIS
- Program records of ITN continuous distribution
INFO: Grants implementing ITN continuous distribution must collect VC-3. This indicator enables tracking progress and performance in ITN continuous distribution among high-risk and vulnerable population groups such as children, pregnant women, prison population and those living in refugee camps as well as those living in emergency situations. The targets are set based on the estimated size of the targeted groups. A good coverage through continuous distributed between mass campaigns also helps to fill the gap created due to decay/loss of ITNs distributed through mass campaigns.
Click here to go to the example logic model with key
CM-2A: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, at public sector health facilities.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator and denominator: OPD register/
- Malaria treatment register
INFO: CM-2A is a Group 1 indicator and must be measured by all malaria grants implementing case management activities. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.
Click here to go to the example logic model with key
Click here to go to the example logic model with key
Click here to go to the example logic model with key
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
CM-1B: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) in the community.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:
- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1B must be collected for grants where funding is allocated towards community testing programs.
Click here to go to the example logic model with key
CM-7: Percentage of districts achieving national target for the proportion of patients with suspected malaria who receive a parasitological test.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-7 is a highly recommended indicator in combination with the CM-1 series. This indicator enables assessing sub-national variations in malaria diagnostic testing coverage among suspected cases of malaria visiting public, community, and private sector health facilities. It informs decisions on prioritization and targeting of subnational units for differentiated support (expansion of testing services, commodities, training, technical support, and supervision).
SPI-2.1: Percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- Health management information system (HMIS)/routine surveillance system
INFO: Grants implementing SMC must collect SPI-2.1 (Group 1 indicator). This indicator is a critical metric for measuring program coverage and completion rates of the required SMC course.
CM-10: Proportion of cases reported to relevant reporting system within 24 hours of diagnosis (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric for surveillance capacity monitoring particularly in elimination settings, where the target should be to achieve full coverage for this indictor. This indicator helps to asses promptness of reporting to the relevant national system.
Click here to go to the example logic model with key
SPI-4: Percentage of districts achieving national target for the proportion of pregnant women and girls attending antenatal services who received three or more doses of intermittent preventive treatment for malaria.
DISAGGREGATIONS: N/ADATA SOURCE: Health information system/routine surveillance systemINFO: SPI-4 is a recommended indicator and is critical for understanding subnational variation in IPTp completion rates among pregnant women and girls. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.
Click here to go to the example logic model with key
O-1a: Proportion of population that slept under an insecticide-treated net the previous night in areas targeted for ITNs.
DISAGGREGATIONS:
- Gender (female, male)
- Targeted risk groups (<5 children, pregnant women, migrants, refugees, IDPs, prisoners, others)
DATA SOURCE:
- Household surveys such as periodic malaria indicator survey, DHS or MICS
- Small area surveys such as LQAS
INFO: This indicator should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. This indicator measures the level of ITN use among all individuals who slept the previous night in surveyed households, regardless of whether those individuals had access to an ITN within their household. It also helps to assess ITN use among targeted risk population groups such as pregnant women and under-five children.
O-1a: Proportion of population that slept under an insecticide-treated net the previous night in areas targeted for ITNs.
DISAGGREGATIONS:
- Gender (female, male)
- Targeted risk groups (<5 children, pregnant women, migrants, refugees, internally displaced people [IDPs], prisoners, others)
- DATA SOURCE:
- Household surveys such as periodic malaria indicator survey, DHS or MICS
- Small area surveys such as LQAS
INFO: This indicator should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. This indicator measures the level of ITN use among all individuals who slept the previous night in surveyed households, regardless of whether those individuals had access to an ITN within their household. It also helps to assess ITN use among targeted risk population groups such as pregnant women and under-five children.
Click here to go to the example logic model with key
VC-6.1: Proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS.
DISAGGREGATIONS: N/ADATA SOURCE:
- Malaria program records for IRS
- Numerator: Program records
- Denominator: HH enumeration data / population census projection
INFO: Grants implementing IRS must collect VC-6.1. Indicator enables assessing campaign effectiveness in terms of proportion of the household population in targeted areas that may have been protected by IRS conducted over the last 12 months.
O-11: Percentage of districts achieving national target for the proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution & list of districts eligible for ITN distribution
- Denominator: Pre-distribution census/ census projection; and list of districts eligible for ITN distribution
INFO: O-11 is a highly recommended indicator that enables assessment of sub-national variations in access to ITNs. The analysis for this indicator informs decisions on prioritization and subnational targeting for differentiated support.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning electronic logistics management information systems (eLMIS), data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted
INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of SMC supplies and provides essential context for interpreting other SMC indicators. When SMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
Click here to go to the example logic model with key
CM-6: Proportion of foci classified as active, residual non-active and cleared (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: The indicator helps to assess the ability of the surveillance system to investigate, map and classify malaria foci in elimination settings. It is an important indicator to track the programmatic impact of elimination efforts over time.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support passive/active case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
VC-1: Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns.
DISAGGREGATIONS: Type of mass campaign (Regular distribution, Emergency distribution)DATA SOURCE: Program records of ITN mass campaignsINFO: This indicator enables tracking progress and performance in ITN mass distribution. The targets are set based on the timing for ITN replacement, procurement and distribution schedule, and a good performance on this indicator is crucial to ensure that programs maintain high household coverage with appropriate ITNs. It is a mandatory indicator in all settings where investments are supporting ITN mass distribution campaign at national and/ or subnational level.
Malaria Indicator Selection Framework
Maxwell Owusu
Created on June 5, 2025
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Essential Course
View
Practical Course
View
Basic Interactive Course
View
Course 3D Style
View
Minimal Course
View
Neodigital CPD Course
View
Laws and Regulations Course
Explore all templates
Transcript
Malaria Indicator Selection Framework
A guide for selecting appropriate Global Fund performance monitoring indicators
Start
How to Use Genially
Navigation Features
Logic Model Table of Contents
Indicator Details
Use the four buttons on the top left of the screen to navigate through the Indcator Selection Frameworks.
Use the table of contents (page 6) to navigate between logic models. The logic models are organized by Global Fund module. Click the home button in the top left corner to return to the table of contents.
Within each logic model, click an indicator box to open a details window. This window includes the indicator definition, disaggregations, data sources, and other key information.
Go to Logic Model Table of Contents
CODE
Go back to previous page
Click on me!
Go to next page
Use the button on the top right to reveal all interactive elements that can be clicked
Open Logic Model key
INPUT
Page 2
Indicator Selection Frameworks Overview
PURPOSE: The Indicator Selection Frameworks are designed to assist in selecting appropriate Global Fund indicators for each intervention. They provide systematic guidance to ensure a comprehensive selection process that meets both mandatory requirements and best practice recommendations. The tool ensures inclusion of all required indicators for each intervention and facilitates the selection of additional indicators to support effective program monitoring. These indicators help measure intervention coverage, outcomes, and the overall impact of malaria interventions. Upon completing this process, users will have a comprehensive list of indicators suitable for inclusion in the Performance Framework.
AUDIENCE: Public Health Monitoring & Evaluation Specialists (PHMES) and Principal Recipients (PRs)
LOGIC MODELS: There are nine logic models, each representing a distinct Global Fund intervention, such as Seasonal Malaria Chemoprevention (SMC), Indoor Residual Spraying (IRS), etc. Each model outlines the inputs, activities/outputs, outcomes, and impacts associated with the intervention. Global Fund malaria indicators have been systematically mapped to their corresponding positions within each logic model.
INPUT
ACTIVITIES/OUTPUTS
OUTCOMES
INPUTS
IMPACTS
IMPACT INDICATORS: The impact indicators are essential and span across all interventions. Since interventions work collectively to achieve the desired impact, these indicators are presented separately. It is recommended that grantees select indicators I-3.1 and I-10, plus at least two additional impact indicators to enable triangulation.Click here to go to the impact indicators.
Page 3
Indicator Selection Frameworks Overview
INDICATOR SUMMARY TABLES: In addition to the logic models, each page includes a summary table listing the relevant Group 1 mandatory indicators, intervention-specific mandatory indicators, recommended non-mandatory indicators, and relevant Resilient and Sustainable Systems for Health (RSSH) grant indicators. For some interventions, different indicators are recommended depending on whether recent Demographic and Health Survey (DHS) or Multiple Indicator Cluster Survey (MICS) results are available.
RSSH INIDICATORS: Where relevant, RSSH indicators have been included to highlight their relevance to malaria interventions. These indicators provide important contextual information that supports the interpretation of malaria-specific data. Grants that include RSSH funding should consider selecting these indicators. However, they are not intended to replace core malaria indicators.
DISAGGREGATIONS: If a selected indicator includes disaggregations, all disaggregated data must be reported. Some disaggregations may be more relevant to specific interventions. If the indicator is collected through a small area survey such as Lot Quality Assurance Sampling (LQAS), disaggregated data may not be feasible to collect due to the limited sample size.
INPUT
Page 4
Indicator Selection Frameworks Overview
RELATED DOCUMENTATION:
The Indicator Selection Framework should be used in conjunction with the following complementary documents:
* Click on document name to open
Global Fund Malaria Indicator Guidance Sheet
Global Fund Modular Framework Handbook
INPUT
Page 4
Indicator Selection Workbook
Download the linked Indicator Selection Workbook and use it alongside the Indicator Selection Frameworks. The workbook can be used to track the indicators selected for inclusion in the grant and the Performance Framework.
Click here to open the Indicator Selection Workbook.
INPUT
Page 4
Key - Example Logic Model
CODE
Elimination Indicator
Non-mandatory indicator recommended for elimination contexts only.
CODE
RSSH Indicator
Grants with RSSH funding should consider reporting this indicator
Indicates a note related to this activity. See bottom right corner of the logic model for details.
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
CM-1A
O-13
CM-10
RSSH O-3
CM-1B
CM-1C
CODE
Non-Mandatory Indicator
Non-mandatory indicator applicable to all settings.
CODE
Group 1 (Mandatory)
This is a mandatory indicator for all grants receiving funding for the intervention and is used in calculating the grant’s Performance Rating.
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
CM-7
CODE
Intervention-Specific Mandatory Indicator
Grants receiving funding for interventions (e.g., G6PD testing, private sector testing, etc.) are required to report on these indicators.
Page 5
Notes related to the asterisk will appear here.
Indicator Selection Frameworks
SEASONAL MALARIA CHEMOPREVENTION
PERENNIAL MALARIA CHEMOPREVENTION
SPI MODULE
KEY
Note: color corresponds to intervention
INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY
Group 1 (Mandatory)
CODE
Intervention-specific Mandatory Indicator
INSECTICIDE TREATED NET MASS CAMPAIGNS
CODE
VECTOR CONTROL MODULE
Reduced malaria incidence and prevalence
Reduced malaria mortality
INSECTICIDE TREATED NET CONTINOUS CAMPAIGNS
Elimination Indicator
CODE
INDOOR RESIDUAL SPRAYING
Non-mandatory Indicator
CODE
CODE
RSSH Indicator
CASE DETECTION: ELIMINATION SETTINGS
CASE MANAGEMENT MODULE
CASE DETECTION: HIGH/MIXED BURDEN
CASE TREATMENT
* Click on the intervention to go to the corresponding logic model *
Page 6
SEASONAL MALARIA CHEMOPREVENTION (SMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement targeted campaigns to administer SMC to children in target age groups during peak transmission seasons
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of SMC as recommended
Decrease in malaria mortality in children
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure SMC medications and identify target districts
Distribute adequate supply of SMC medications to implementing districts before peak transmission season
RSSH O-3
SPI-2.1
Districts monitor and achieve target SMC coverage among children in the target age group
SPI-5
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 7
SEASONAL MALARIA CHEMOPREVENTION (SMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement targeted campaigns to administer SMC to children in target age groups during peak transmission seasons
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of SMC as recommended
Decrease in malaria mortality in children
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure SMC medications and identify target districts
Distribute adequate supply of SMC medications to implementing districts before peak transmission season
RSSH O-3
SPI-2.1
Districts monitor and achieve target SMC coverage among children in the target age group
SPI-5
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 7
PERENNIAL MALARIA CHEMOPREVENTION (PMC)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Conduct planning using local epidemiological and intervention data, along with programmatic gap tables, to procure PMC medications and identify target districts
Administer PMC to children in target age group in perennial transmission areas through EPI or other distribution channels
Decrease in malaria and severe malaria incidence and prevalence in children
Children in the target age group receive the full course of PMC as recommended
Decrease in malaria mortality in children
Distribute adequate supply of PMC medications to implementing districts for year-round administration
SPI-3.1
RSSH O-3
Establish integrated malaria services within Expanded Program on Immunization (EPI)
If Intermittent prevention treatment of malaria in school-aged children (IPTsc) is being implemented, it should be documented. There are no specific indicators for these interventions.
Page 8
INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY (IPTp)
OUTCOMES
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
* Click on indicator for additional information *
Distribute adequate supply of IPTp medications to facilities and communities in implementing districts
Administer recommended doses of IPTp to pregnant women and girls through ANC and community-based services
Pregnant women and girls receive IPTp through ANC and community-based services
Pregnant women and girls receive first dose of IPTp
Decrease in malaria related pregnancy complications and low-weight and premature births
Decrease in malaria-associated mortality among pregnant women and girls, and among neonates
Conduct planning using local epidemiological data, along with programmatic gap tables, to procure IPTp medications for target districts
O-17
RSSH O-3
Pregnant women and girls receive 3+ doses of IPTp
Establish integrated malaria services within antenatal care (ANC)
SPI-1
Districts monitor and achieve target IPTp coverage among pregnant women and girls
SPI-4
Page 9
ITN MASS CAMPAIGNS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
IMPACTS
* Click on indicator for additional information *
Conduct social and behavior change (SBC) activities related to ITN use
Distribute adequate supply of ITNs to implementing districts
Distribute ITNs to at-risk populations through mass campaigns
Increase in at-risk population sleeping under ITNs
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Decrease in malaria mortality across all age groups
Population at risk receives ITN and has access to an ITN within their household
Conduct planning using local epidemiological and entomological data, along with programmatic gap tables, to procure effective ITNs for implementing districts
O-3
O-1a
O-10
VC-1
O-2
Participating districts implement and track ITN distribution activities to achieve target population coverage
O-11
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 10
ITN CONTINUOUS DISTRIBUTION
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
IMPACTS
* Click on indicator for additional information *
Conduct SBC activities related to ITN use
Increase in at-risk population sleeping under ITNs
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Decrease in malaria mortality across all age groups
Distribute an adequate supply of ITNs for each distribution channel including, as relevant: ANC, EPI, schools, and community
Population at risk receives ITN and has access to an ITN within their household
Conduct planning using local epidemiological and entomological data, along with programmatic gap tables, to procure effective ITNs for implementing districts
Distribute ITNs to at-risk populations through ANC, EPI, school, and community delivery channels
VC-3
O-3
O-1a
O-10
O-2
Participating districts implement and track ITN distribution activities to achieve target population coverage
O-11
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 11
INDOOR RESIDUAL SPRAYING (IRS)
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
OUTCOMES
* Click on indicator for additional information *
Implement IRS campaign
Decrease in malaria and severe malaria incidence and prevalence in all age groups
Households and structures are sprayed using appropriate insecticide to achieve target population coverage in all targeted areas
Decrease in malaria mortality across all age groups
Conduct planning using local epidemiological and entomological data, the number of structures requiring spraying, and programmatic gap tables to procure effective IRS insecticides for implementing districts
Distribute adequate supply of residual insecticides to implementing districts
VC-6.1
Participating districts implement and track IRS activities to achieve target population coverage in each district
VC-7
If other environmental vector control strategies (e.g., bacterial larvicides, attractive toxic sugar baits, etc.) are being implemented, they should be documented. There are no specific indicators for these interventions.
Page 12
CASE MANAGEMENT: CASE DETECTION (ELIMINATION SETTINGS)
ACTIVITIES / OUTPUTS
INPUTS
OUTCOMES
ACTIVE CASE DETECTION
Detect and report symptomatic and asymptomatic malaria cases among screened population
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Screen at-risk populations for malaria using RDT or microscopy
Investigate and classify confirmed malaria cases and foci
Proceed to Treatment Pathway
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
O-13
CM-6
CM-10
CM-5
RSSH O-3
O-9
Conduct SBC activities related to malaria case management
PASSIVE CASE DETECTION
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
CM-1A
CM-9
O-13
CM-10
RSSH O-3
CM-1B
CM-1C
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
Following foci investigation, targeted mass drug administration (MDA) may be conducted to support elimination efforts or reduce transmission
Page 13
CM-7
CASE MANAGEMENT: CASE DETECTION (HIGH-BURDEN SETTINGS)
ACTIVITIES / OUTPUTS
INPUTS
OUTCOMES
* Click on indicator for additional information *
Conduct SBC activities related to malaria case management
Distribute adequate parasitological tests (RDT or microscopy) to implementing districts
Perform parasitological testing (microscopy or RDT) on patients presenting with suspected malaria
Providers recommend treatment for confirmed malaria
Confirm and report malaria diagnoses among symptomatic patients
Proceed to Treatment Pathway
Conduct planning using local epidemiological data and programmatic gap tables to procure parasitological tests (RDT or microscopy) for implementing districts
CM-1A
RSSH O-3
O-13
CM-1B
CM-1C
Target districts implement testing protocols to achieve target testing rates among suspected malaria cases
CM-7
Page 14
CASE MANAGEMENT: TREATMENT (ALL SETTINGS)
OUTCOMES
IMPACTS
INPUTS
ACTIVITIES / OUTPUTS
* Click on indicator for additional information *
Health care providers test for patients with P. vivax to assess G6PD deficiencies
Patients with P. vivax receive G6PD deficiency testing before being prescribed treatment
Decrease in severe malaria requiring admission
Conduct SBC activities related to malaria case management
CM-11
P.vivax
Distribute adequate supply of antimalarials and G6PD tests to implementing districts
Patients with confirmed malaria receive treatment with appropriate first-line antimalarials
Health care providers prescribe appropriate first-line treatment to patients with confirmed malaria
Parasite is cleared
Decrease in transmission due to early identification and treatment in cases
Decrease in malaria mortality in all age groups
Conduct planning using local epidemiological data, therapeutic efficacy studies, and programmatic gap tables to procure effective antimalarials and G6PD tests for implementing districts
CM-2A
RSSH O-3
CM-2B
Adequate number of healthcare providers
Elimination settings: Districts achieve subnational elimination of cases
CM-2C
Participating districts implement treatment protocols to achieve target treatment rates among confirmed malaria cases
RSSH/PP O-3
CM-8
Page 15
CROSS-INTERVENTION IMPACT INDICATORS
Impact indicators are cross-cutting across interventions and are used to track progress toward primary objectives, such as reductions in case incidence and mortality rates. It is recommended that grants select I-3.1, I-10, and at least 2 additional impact indicators to support triangulation.
Page 16
SPI-1: Proportion of pregnant women and girls attending antenatal services who received three or more doses of intermittent preventive treatment for malaria.
DISAGGREGATIONS: Age (<15, 15+)DATA SOURCE: HMIS/routine surveillance systemINFO: SPI-1 is a mandatory Group 1 indicator required for all grants implementing IPTp. SPI-1 measures completion rates of three or more recommended doses of IPTp.
Click here to go to the example logic model with key
Click here to go to the example logic model with key
Click here to go to the example logic model with key
CM-2B: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, in the community.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator & Denominator: Malaria treatment register/ Community worker records
INFO: CM-2B must be collected by grants where community treatment is funded. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.O-2: Proportion of population with access to an ITN within their household.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-2 measures household-level ITN availability and is key for evaluating whether distribution translates into accessible protection for all household members. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups.
SPI-3.1: Proportion of children in the target age group who received the full number of doses of perennial malaria chemoprevention (PMC) according to national policy.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: Grants implementing PMC must collect SPI-3.1. This indicator is a critical metric for measuring program coverage and completion rates of the required PMC course.O-2: Proportion of population with access to an ITN within their household.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-2 measures household-level ITN availability and is key for evaluating whether distribution translates into accessible protection for all household members. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups.
Click here to go to the example logic model with key
Click here to go to the example logic model with key
CM-10: Proportion of cases reported to relevant reporting system within 24 hours of diagnosis (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric for surveillance capacity monitoring particularly in elimination settings, where the target should be to achieve full coverage for this indictor. This indicator helps to assess promptness of reporting to the relevant national system.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of SMC supplies and provides essential context for interpreting other SMC indicators. When SMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
CM-11: Proportion of P. vivax cases tested for G6PD deficiency.
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: CM-11 must be measured in all grants where G6PD testing is funded. This indicator is relevant for settings with P. vivax or mixed infections where treatment with primaquine or tafenoquine would be required for clearance of the liver stage of the parasite. This indicator assesses trends in testing coverage for G6PD deficiency in patients receiving primaquine or tafenoquine for radical cure of P. vivax.
CM-1B: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) in the community.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1B must be collected for grants where funding is allocated towards community testing programs.O-3: Proportion of the population with access to an ITN in their household that slept under an ITN the previous night.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-3 measures actual ITN utilization among those with access to an ITN to assess behavioral uptake and real protection achieved. This indicator is suitable especially in burden reduction settings where national population-based surveys and/ or small area surveys are planned. It should be included and the source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. The indicator could be calculated by dividing O-1a (numerator) by O-2 (denominator).
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of PMC supplies and provides essential context for interpreting other PMC indicators. When PMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
O-17: Number of women receiving one dose of IPTp.
DISAGGREGATIONS: N/ADATA SOURCE: HMIS (ANC and community registers)INFO: As countries diversify the avenues for the delivery of IPTp beyond the ANC clinics, this indicator seeks to assess access to at least one dose of IPTp in the health facility or community. O-17 helps programs understand uptake of the first IPTp dose during pregnancy, while SPI-1 measures completion rates of three or more recommended doses. While O-17 is not factored into grant performance evaluations, it provides essential context for interpreting SPI-1 results.
SPI-5: Percentage of targeted districts achieving national targets for the percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: SPI-5 serves as a critical indicator for understanding subnational variation in SMC completion rates in children. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine surveillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.RSSH/PP O-3: Density of active health workers per 10,000 population.
DISAGGREGATIONS: Occupation group (Physicians, Nurses, Midwives, Laboratory technicians, Pharmacists, CHWs) DATA SOURCE: Human Resources Health Information System (HRHIS) or any other Health WorkfoRce registry or database. INFO: RSSH/PP O3 assesses whether there are sufficient health workers available to provide malaria treatment.
O-3: Proportion of the population with access to an ITN in their household that slept under an ITN the previous night.
DISAGGREGATIONS: N/ADATA SOURCE: Household surveys such as periodic malaria indicator survey, DHS or MICSINFO: O-3 measures actual ITN utilization among those with access to an ITN to assess behavioral uptake and real protection achieved. This indicator is suitable especially in burden reduction settings where national population-based surveys and/or small area surveys are planned. It should be included and the source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. The indicator could be calculated by dividing O-1a (numerator) by O-2 (denominator).
Click here to go to the example logic model with key
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine surveillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine survillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimated cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.CM-1C: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at private sector sites.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1C must be collected for grants where funding is allocated towards private testing programs.O-10: Proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution
- Denominator: Pre-distribution census/ census projection
INFO: O-10 measures theoretical population coverage to assess distribution adequacy relative to at-risk populations. The indicator is critical for evaluating whether sufficient nets are distributed to achieve protective coverage. This indicator becomes increasing useful as the paucity of data from population-based surveys becomes a real challenge for programmatic monitoring of trends in access to vector control interventions, particularly ITNs.RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support passive case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
SPI-5: Percentage of targeted districts achieving national targets for the percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: N/ADATA SOURCE:
- Health information system/routine surveillance system
- Mass campaign registers
INFO: SPI-5 serves as a critical indicator for understanding subnational variation in SMC completion rates in children. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of IPTp supplies and provides essential context for interpreting other IPTp indicators. When IPTp coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
O-10: Proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution
- Denominator: Pre-distribution census/ census projection
INFO: O-10 measures theoretical population coverage to assess distribution adequacy relative to at-risk populations. The indicator is critical for evaluating whether sufficient nets are distributed to achieve protective coverage. This indicator becomes increasing useful as the paucity of data from population-based surveys becomes a real challenge for programmatic monitoring of trends in access to vector control interventions, particularly ITNs.CM-1A: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at a public sector health facility.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1A is a Group 1 indicator and must be measured by all grants implementing case management activities.CM-1C: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at private sector sites.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1C must be collected for grants where funding is allocated towards private testing programs.O-9: Annual blood examination rate (ABER): Number of people receiving a parasitological test during 1 year out of the total population at risk.
DISAGGREGATIONS: Case detection (active, passive)DATA SOURCE: Health information system/routine surveillance systemINFO: Analysis of ABER enables assessing malaria diagnostic effort through analysis of the number of patients receiving a parasitological test for malaria (blood slide for microscopy or malaria rapid diagnostic test) out of the total population living in malarious areas.
CM-7: Percentage of districts achieving national target for the proportion of patients with suspected malaria who receive a parasitological test.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-7 is recommended to be collected by all grants receiving funding for Case Management. This indicator enables assessing sub-national variations in malaria diagnostic testing coverage among suspected cases of malaria visiting public, community, and private sector health facilities. It informs decisions on prioritization and targeting of subnational units for differentiated support (expansion of testing services, commodities, training, supervision, etc.).
SPI-2.1: Percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- Mass campaign registers
INFO: Grants implementing SMC must collect SPI-2.1 (Group 1 indicator). This indicator is a critical metric for measuring program coverage and completion rates of the required SMC course.Click here to go to the example logic model with key
CM-5: Proportion of confirmed cases classified (elimination settings).
DISAGGREGATIONS: Source of infection (indigenous, introduced, relapsing, recrudescent, induced, imported)DATA SOURCE: HMIS/routine surveillance systemINFO: The indicator enables assessing compliance with the third component (tracking) of the test, treat and track (T3) cascade, in elimination settings. It also helps to assess the promptness of the surveillance system. Countries may have their own rules on reporting, investigation and classification (e.g., 1,3, 7-day rule, etc.).
CM-9: Proportion of detected malaria patients that contacted health services within 48 hours of symptoms (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric of prompt access to care, particularly in elimination settings, where the target should be to achieve full coverage for this indictor.
Click here to go to the example logic model with key
Indicator Additional Details – Example View
O-13: Proportion of malaria cases detected by the surveillance system.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Health information system/routine survillance system
- Denominator: WHO estimate; or a country estimate, if justified and agreed to be more accurate.
INFO: This indicator enables estimating the reach of the health system to detect, treat and notify all the malaria cases in the country. It enables assessing what proportion of estimated malaria cases has actually been detected, confirmed, treated and reported (and what proportion has been “missing”).This gives an indication of the gap between estimateed cases and notified cases of malaria, and where additional efforts should be spent to provide access to populations.CM-2C: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, at private sector sites.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator and denominator: OPD register/Malaria treatment register/ Pharmacy/ records
INFO: CM-2C should be measured in grants where private treatment is funded. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.CM-1A: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) at a public sector health facility.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ OPD register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1A is a Group 1 indicator and must be measured by all grants implementing case management activities.Click here to go to the example logic model with key
O-11: Percentage of districts achieving national target for the proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution & list of districts eligible for ITN distribution
- Denominator: Pre-distribution census/ census projection; and list of districts eligible for ITN distribution
INFO: O-11 is a highly recommended indicator that enables assessment of sub-national variations in access to ITNs. The analysis for this indicator informs decisions on prioritization and subnational targeting for differentiated support.VC-7: Percentage of districts achieving national target for the proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS.
DISAGGREGATIONS: N/ADATA SOURCE: Malaria program records for IRSINFO: VC-7 is highly recommended for grants implementing IRS. VC-7 measures geographic equity in IRS delivery by tracking district-level performance against national standards. This indicator is essential for identifying underperforming areas and optimizing resource allocation for vector control.
CM-8: Percentage of districts achieving national targets for the proportion of patients with confirmed malaria who received first-line antimalarial treatment.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-8 is a highly recommended indicator in combination with the CM-2 series. This indicator enables assessment of sub-national variations in first-line treatment coverage among confirmed cases of malaria diagnosed at public, community, and private sector health facilities. It informs decisions on prioritization and targeting of sub-national units for differentiated support - in terms of interventions, approaches, technical support, and supervision.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support case treatment by assessing antimalarial supply availability at health facilities. This indicator is critical for understanding the availability of treatment supplies and provides essential context for interpreting other case management treatment indicators. When treatment coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
VC-3: Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution.
DISAGGREGATIONS: At risk population group (Children 0-5, Pregnant women, School children, people in emergency situation, others)DATA SOURCE:
- HMIS
- Program records of ITN continuous distribution
INFO: Grants implementing ITN continuous distribution must collect VC-3. This indicator enables tracking progress and performance in ITN continuous distribution among high-risk and vulnerable population groups such as children, pregnant women, prison population and those living in refugee camps as well as those living in emergency situations. The targets are set based on the estimated size of the targeted groups. A good coverage through continuous distributed between mass campaigns also helps to fill the gap created due to decay/loss of ITNs distributed through mass campaigns.Click here to go to the example logic model with key
CM-2A: Proportion of patients with confirmed malaria who received first-line antimalarial treatment, according to national policy, at public sector health facilities.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- HMIS
- Numerator and denominator: OPD register/
- Malaria treatment register
INFO: CM-2A is a Group 1 indicator and must be measured by all malaria grants implementing case management activities. This indicator assesses compliance with the second component (treatment) of the T3 cascade; and contributes to assessment of quality of case management.Click here to go to the example logic model with key
Click here to go to the example logic model with key
Click here to go to the example logic model with key
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
CM-1B: Proportion of patients with suspected malaria who received a parasitological test (microscopy or RDT) in the community.
DISAGGREGATIONS:
- Age (<5, 5+)
- Type of testing (microscopy, rapid diagnostic test)
DATA SOURCE:- HMIS
- Numerator: Patient treatment register (type of test column)
- Denominator: Suspect register/ patient treatment register (initial or provisional diagnosis column)
INFO: CM-1B must be collected for grants where funding is allocated towards community testing programs.Click here to go to the example logic model with key
CM-7: Percentage of districts achieving national target for the proportion of patients with suspected malaria who receive a parasitological test.
DISAGGREGATIONS: Type of provider (public, private, community)DATA SOURCE: HMIS/routine surveillance systemINFO: CM-7 is a highly recommended indicator in combination with the CM-1 series. This indicator enables assessing sub-national variations in malaria diagnostic testing coverage among suspected cases of malaria visiting public, community, and private sector health facilities. It informs decisions on prioritization and targeting of subnational units for differentiated support (expansion of testing services, commodities, training, technical support, and supervision).
SPI-2.1: Percentage of children who received the full number of cycles of seasonal malaria chemoprevention (SMC) per transmission season in the targeted areas.
DISAGGREGATIONS: Age (<5, 5+)DATA SOURCE:
- Mass campaign registers
INFO: Grants implementing SMC must collect SPI-2.1 (Group 1 indicator). This indicator is a critical metric for measuring program coverage and completion rates of the required SMC course.CM-10: Proportion of cases reported to relevant reporting system within 24 hours of diagnosis (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: This indicator represents an important metric for surveillance capacity monitoring particularly in elimination settings, where the target should be to achieve full coverage for this indictor. This indicator helps to asses promptness of reporting to the relevant national system.
Click here to go to the example logic model with key
SPI-4: Percentage of districts achieving national target for the proportion of pregnant women and girls attending antenatal services who received three or more doses of intermittent preventive treatment for malaria.
DISAGGREGATIONS: N/ADATA SOURCE: Health information system/routine surveillance systemINFO: SPI-4 is a recommended indicator and is critical for understanding subnational variation in IPTp completion rates among pregnant women and girls. This district-level indicator enables implementing partners to identify geographical areas that are not achieving target coverage rates and may require additional programmatic support or resource allocation.
Click here to go to the example logic model with key
O-1a: Proportion of population that slept under an insecticide-treated net the previous night in areas targeted for ITNs.
DISAGGREGATIONS:
- Gender (female, male)
- Targeted risk groups (<5 children, pregnant women, migrants, refugees, IDPs, prisoners, others)
DATA SOURCE:- Household surveys such as periodic malaria indicator survey, DHS or MICS
- Small area surveys such as LQAS
INFO: This indicator should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. This indicator measures the level of ITN use among all individuals who slept the previous night in surveyed households, regardless of whether those individuals had access to an ITN within their household. It also helps to assess ITN use among targeted risk population groups such as pregnant women and under-five children.O-1a: Proportion of population that slept under an insecticide-treated net the previous night in areas targeted for ITNs.
DISAGGREGATIONS:
- Household surveys such as periodic malaria indicator survey, DHS or MICS
- Small area surveys such as LQAS
INFO: This indicator should be included and source of data defined in all settings where increasing access to and use of ITNs is a priority investment, either for the whole population or targeted population groups. This indicator measures the level of ITN use among all individuals who slept the previous night in surveyed households, regardless of whether those individuals had access to an ITN within their household. It also helps to assess ITN use among targeted risk population groups such as pregnant women and under-five children.Click here to go to the example logic model with key
VC-6.1: Proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS.
DISAGGREGATIONS: N/ADATA SOURCE:
- Malaria program records for IRS
- Numerator: Program records
- Denominator: HH enumeration data / population census projection
INFO: Grants implementing IRS must collect VC-6.1. Indicator enables assessing campaign effectiveness in terms of proportion of the household population in targeted areas that may have been protected by IRS conducted over the last 12 months.O-11: Percentage of districts achieving national target for the proportion of population at risk potentially covered by distributed ITNs.
DISAGGREGATIONS: N/ADATA SOURCE:
- Numerator: Program records for ITN distribution & list of districts eligible for ITN distribution
- Denominator: Pre-distribution census/ census projection; and list of districts eligible for ITN distribution
INFO: O-11 is a highly recommended indicator that enables assessment of sub-national variations in access to ITNs. The analysis for this indicator informs decisions on prioritization and subnational targeting for differentiated support.RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning electronic logistics management information systems (eLMIS), data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness by assessing supply availability at health facilities. This indicator is critical for understanding the availability of SMC supplies and provides essential context for interpreting other SMC indicators. When SMC coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions.
Click here to go to the example logic model with key
CM-6: Proportion of foci classified as active, residual non-active and cleared (elimination settings).
DISAGGREGATIONS: N/ADATA SOURCE: HMIS/routine surveillance systemINFO: The indicator helps to assess the ability of the surveillance system to investigate, map and classify malaria foci in elimination settings. It is an important indicator to track the programmatic impact of elimination efforts over time.
RSSH O-3: On-Shelf Availability: Percentage of facilities with tracer health products for the three diseases- HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting.
DISAGGREGATIONS: Type of Health Product (HIV - First Line Drugs, HIV - Second Line Drugs, HIV - Diagnostics, TB - First Line Drugs, TB - Second Line Drugs, TB - Diagnostics, Malaria - First Line Drugs, Malaria - Second Line Drugs, Malaria - Diagnostics) DATA SOURCE: (1) For countries that have functioning eLMIS systems, data source would be stock status reports from health facilities taken from eLMIS (2) For remaining countries, an on-site survey of a sampled list of health facilities to be conducted INFO: RSSH-O3 measures health system readiness to support passive/active case detection by assessing diagnostic supply availability at health facilities. This indicator is critical for understanding the availability of testing supplies and provides essential context for interpreting other case management testing indicators. When testing coverage appears low, RSSH-O3 helps determine whether the issue stems from supply constraints or other programmatic factors, enabling more targeted interventions to improve diagnostic capacity.
VC-1: Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns.
DISAGGREGATIONS: Type of mass campaign (Regular distribution, Emergency distribution)DATA SOURCE: Program records of ITN mass campaignsINFO: This indicator enables tracking progress and performance in ITN mass distribution. The targets are set based on the timing for ITN replacement, procurement and distribution schedule, and a good performance on this indicator is crucial to ensure that programs maintain high household coverage with appropriate ITNs. It is a mandatory indicator in all settings where investments are supporting ITN mass distribution campaign at national and/ or subnational level.